Current Status of Glycemic Control of Patients with Diabetes in Korea: The Fifth Korea National Health and Nutrition Examination Survey |
Jeon, Ja Young
(Department of Endocrinology and Metabolism, Ajou University School of Medicine)
Kim, Dae Jung (Department of Endocrinology and Metabolism, Ajou University School of Medicine) Ko, Seung-Hyun (Division of Endocrinology and Metabolism, Department of Internal Medicine, The Catholic University of Korea College of Medicine) Kwon, Hyuk-Sang (Division of Endocrinology and Metabolism, Department of Internal Medicine, The Catholic University of Korea College of Medicine) Lim, Soo (Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine) Choi, Sung Hee (Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine) Kim, Chul Sik (Division of Endocrinology and Metabolism, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine) An, Jee Hyun (Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine) Kim, Nan Hee (Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine) Won, Jong Chul (Department of Internal Medicine, Mitochondrial Research Group, Inje University Sanggye Paik Hospital, Inje University College of Medicine) Kim, Jae Hyeon (Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) Cha, Bong-Yun (Division of Endocrinology and Metabolism, Department of Internal Medicine, The Catholic University of Korea College of Medicine) Song, Kee-Ho (Department of Internal Medicine, Konkuk University School of Medicine) Taskforce Team of Diabetes Fact Sheet of the Korean Diabetes Association (Taskforce Team of Diabetes Fact Sheet of the Korean Diabetes Association) |
1 | Statistics Korea: Causes of death statistics 2012. Available from: http://kostat.go.kr (updated 2013 Sep 25). |
2 | Nolan CJ, Damm P, Prentki M. Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet 2011;378:169-81. DOI ScienceOn |
3 | Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 2002;287:2570-81. DOI ScienceOn |
4 | Jeon JY, Ko SH, Kwon HS, Kim NH, Kim JH, Kim CS, Song KH, Won JC, Lim S, Choi SH, Jang MJ, Kim Y, Oh K, Kim DJ, Cha BY; Taskforce Team of Diabetes Fact Sheet of the Korean Diabetes Association. Prevalence of diabetes and prediabetes according to fasting plasma glucose and HbA1c. Diabetes Metab J 2013;37:349-57. DOI ScienceOn |
5 | Choi YJ, Kim HC, Kim HM, Park SW, Kim J, Kim DJ. Prevalence and management of diabetes in Korean adults: Korea National Health and Nutrition Examination Surveys 1998-2005. Diabetes Care 2009;32:2016-20. DOI ScienceOn |
6 | Task Force Team for Basic Statistical Study of Korean Diabetes Mellitus of Korean Diabetes Association, Park IB, Kim J, Kim DJ, Chung CH, Oh JY, Park SW, Lee J, Choi KM, Min KW, Park JH, Son HS, Ahn CW, Kim H, Lee S, Lee IB, Choi I, Baik SH. Diabetes epidemics in Korea: reappraise nationwide survey of diabetes "diabetes in Korea 2007". Diabetes Metab J 2013;37:233-9. DOI ScienceOn |
7 | Ali MK, Bullard KM, Saaddine JB, Cowie CC, Imperatore G, Gregg EW. Achievement of goals in U.S. diabetes care, 1999-2010. N Engl J Med 2013;368:1613-24. DOI ScienceOn |
8 | Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, Zinman B; Professional Practice Committee American Diabetes Association; European Association for the Study of Diabetes. Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2006;49:1711-21. DOI ScienceOn |
9 | Yu NC, Su HY, Chiou ST, Yeh MC, Yeh SW, Tzeng MS, Sheu WH. Trends of ABC control 2006-2011: a National Survey of Diabetes Health Promotion Institutes in Taiwan. Diabetes Res Clin Pract 2013;99:112-9. DOI ScienceOn |
10 | UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53. DOI ScienceOn |
11 | Wajchenberg BL. beta-cell failure in diabetes and preservation by clinical treatment. Endocr Rev 2007;28:187-218. DOI ScienceOn |
12 | Drucker DJ, Sherman SI, Gorelick FS, Bergenstal RM, Sherwin RS, Buse JB. Incretin-based therapies for the treatment of type 2 diabetes: evaluation of the risks and benefits. Diabetes Care 2010;33:428-33. DOI ScienceOn |
13 | Walter H, Lubben G. Potential role of oral thiazolidinedione therapy in preserving beta-cell function in type 2 diabetes mellitus. Drugs 2005;65:1-13. DOI ScienceOn |
14 | Cariou B, Charbonnel B, Staels B. Thiazolidinediones and PPARgamma agonists: time for a reassessment. Trends Endocrinol Metab 2012;23:205-15. DOI ScienceOn |
15 | Campbell JE, Drucker DJ. Pharmacology, physiology, and mechanisms of incretin hormone action. Cell Metab 2013;17:819-37. DOI ScienceOn |